首頁 > 市場調查報告書 > 醫療設備

感測器生技設備

市場調查報告書

商品編碼

1824205

生物感測器市場 - 預測 2025-2030

Biosensors Market - Forecasts from 2025 to 2030

出版日期: 2025年08月16日 | 出版商:

Knowledge Sourcing Intelligence | 英文 149 Pages | 商品交期: 最快1-2個工作天內

價格

簡介目錄

生物感測器市場預計將從 2025 年的 370.55 億美元成長到 2030 年的 659.17 億美元，複合年成長率為 12.21%。

生物感測器是一種先進的診斷設備，其精密的感測技術能夠準確地檢測和監測各種醫療狀況，使其成為現代醫療保健服務的基本工具。這些設備在血糖值監測、妊娠檢測和膽固醇評估等關鍵醫療應用中特別有效，並已成為臨床和居家醫療管理的重要組成部分。

該技術的主要優勢在於它能夠提供精確、即時的生物參數測量，以支援臨床決策和患者自我管理通訊協定。生物感測器已成為重大健康狀況的重要診斷工具，尤其是癌症檢測和糖尿病管理，早期檢測和持續監測對患者預後和治療效果有重大影響。

不斷擴展的應用組合反映了該技術在各種醫療保健場景中的多功能性和可靠性。醫療保健提供者越來越依賴生物感測器技術來提供快速、準確的診斷資訊，以支持及時的干涉策略，同時減少對需要較長處理時間和專業設施的傳統實驗室檢測方法的依賴。

市場動態和醫療保健產業影響

生物感測器市場正呈現強勁成長勢頭，主要得益於其在醫療保健領域的日益普及，以及需要持續監測的慢性病發病率的不斷上升。全球慢性病發病率的上升，對能夠支持長期患者管理通訊協定的診斷技術的需求持續成長。

人工智慧和物聯網等技術進步的融合正在增強生物感測器的功能和潛在應用，實現更複雜的數據分析、更高的診斷準確性和增強的連接性，以支援綜合醫療保健系統。

醫療產業注重可攜式、經濟高效且反應迅速的診斷解決方案，這與生物感測器技術的特性完美契合。早期準確的疾病識別是改善患者預後和生存率的關鍵因素，因此對能夠在各種醫療環境中提供可靠結果的先進診斷技術的需求持續成長。

隨著慢性病和文明病的增多，消費者越來越傾向於定期監測致病活動，這一趨勢支撐著生物感測器市場的持續成長。全球人口老化以及奈米技術的進步使得生物感測器更加普及且更具成本效益，從而將市場拓展至更廣泛的患者群體。

創新與產品開發

生物感測器市場受益於檢測方法和設備設計的持續創新，各公司正在開發日益複雜的解決方案來應對特定的醫療挑戰。非侵入式檢測技術是其發展的關鍵領域，基於唾液的血糖監測系統為傳統的血液檢測方法提供了替代方案。

先進的生物感測器設計融合了快速檢測細菌和病毒的功能，能夠立即評估是否需要進一步諮詢或檢測。此類技術透過提供早期篩檢能力來指南後續的護理決策，從而簡化醫療保健流程。

穿戴式生物感測器技術正展現出強勁的創新勢頭，其設備能夠即時監測生理狀況，包括水合狀態和電解質成分分析。這些系統整合了藍牙連接和行動應用程式，可提供持續的健康監測以及自動化的建議和警報，從而建立全面的健康管理解決方案。

地理市場領導與策略發展

北美憑藉著密集的企業創新活動以及包括人工智慧在內的先進技術的整合，保持著市場主導地位。區域市場的發展反映了集中的研發能力、支持創新的監管基礎設施以及成熟的醫療技術應用模式。

製藥公司與領先研究機構之間的策略夥伴關係關係彰顯了業界對推動生物感測器技術應用的決心。這些合作致力於開發整合生物感測器、生物電子學和響應式給藥系統的整合解決方案，以打造全面的醫療管理平台。

專用生物感測器應用（例如用於工業和農業的干涉測量系統）製造能力的提升，顯示市場已超越傳統醫療應用，走向多元化。這些發展標誌著人們日益認知到生物感測器技術在需要精確生物或化學檢測能力的多個工業領域的適用性。

未來市場趨勢

行業專家預測，由於技術創新、醫療應用的不斷擴大以及與支持全面患者照護管理和監測解決方案的數位健康平台的日益融合，生物感測器市場將繼續擴張。

本報告的主要優點

深刻分析：獲得深入的市場洞察，重點關注客戶細分、政府政策和社會經濟因素、消費者偏好、垂直行業和其他細分市場，涵蓋主要地區和新興地區。
競爭格局：了解主要企業所採用的策略策略，並了解正確策略的市場滲透潛力。
市場促進因素和未來趨勢：探索動態因素和關鍵市場趨勢以及它們將如何影響未來的市場發展。
可行的建議：利用洞察力來制定策略決策，在動態環境中開闢新的業務流和收益。
受眾廣泛：對於新興企業、研究機構、顧問、中小企業和大型企業來說，既有利又划算。

它有什麼用途？

產業與市場洞察、商業機會評估、產品需求預測、打入市場策略、地理擴張、資本投資決策、法律規範與影響、新產品開發、競爭影響

分析範圍

歷史資料（2022-2024）和預測資料（2025-2030）
成長機會、挑戰、供應鏈前景、法規結構、客戶行為和趨勢分析
競爭對手定位、策略和市場佔有率分析
按部門和地區（國家）分類的收益成長和預測分析
公司概況（策略、產品、財務資訊、主要趨勢等）

介紹
北美洲
- 按類型
- 按用途
- 按最終用戶
- 按國家
  - 美國
  - 加拿大
  - 墨西哥
南美洲
- 按類型
- 按用途
- 按最終用戶
- 按國家
  - 巴西
  - 阿根廷
  - 其他
歐洲
- 按類型
- 按用途
- 按最終用戶
- 按國家
  - 德國
  - 法國
  - 英國
  - 義大利
  - 西班牙
  - 其他
中東和非洲
- 按類型
- 按用途
- 按最終用戶
- 按國家
  - 沙烏地阿拉伯
  - 阿拉伯聯合大公國
  - 以色列
  - 其他
亞太地區
- 按類型
- 按用途
- 按最終用戶
- 按國家
  - 中國
  - 印度
  - 日本
  - 韓國
  - 印尼
  - 泰國
  - 台灣
  - 澳洲
  - 其他

第9章競爭格局及分析

主要企業和策略分析
市佔率分析
企業合併、協議、商業合作
競爭對手儀表板

第10章：公司簡介

Abott Laboratories
Bio-Rad Laboratories Inc.
Sartorius AG
Nix Biosensors
Universal Biosensors
Pinnacle Technology Inc.
Dexcom Inc.
Analog Devices, Inc.
STMicroelectronics
Malvern Panalytical Ltd（Spectris）

第11章附錄

貨幣
先決條件
基準年和預測年時間表
相關人員的主要利益
分析方法
簡稱

圖表列表

表格列表

簡介目錄

Product Code: KSI061614273

The biosensors market is expected to grow from USD 37.055 billion in 2025 to USD 65.917 billion in 2030, at a CAGR of 12.21%.

Biosensors represent sophisticated diagnostic instruments that have become fundamental tools in modern healthcare delivery, enabling precise detection and monitoring of various medical conditions through advanced sensing technologies. These devices demonstrate particular efficacy in critical healthcare applications including blood glucose monitoring, pregnancy detection, and cholesterol level assessment, establishing themselves as essential components in both clinical and home-based healthcare management.

The technology's primary strength lies in its capability to provide accurate, real-time biological parameter measurements that support clinical decision-making and patient self-management protocols. Biosensors have emerged as key diagnostic instruments for major health conditions, particularly cancer detection and diabetes management, where early identification and continuous monitoring significantly impact patient outcomes and treatment effectiveness.

The expanding application portfolio reflects the technology's versatility and reliability across diverse medical scenarios. Healthcare providers increasingly rely on biosensor technology to deliver rapid, accurate diagnostic information that supports timely intervention strategies while reducing dependency on traditional laboratory-based testing methods that require extended processing times and specialized facilities.

Market Growth Dynamics and Healthcare Sector Influence

The biosensors market demonstrates robust growth trajectory driven primarily by expanding healthcare sector adoption and the increasing prevalence of chronic medical conditions requiring continuous monitoring. The rising global incidence of chronic illnesses creates sustained demand for diagnostic technologies capable of supporting long-term patient management protocols.

Technological advancement integration, including artificial intelligence and Internet of Things capabilities, has enhanced biosensor functionality and expanded application possibilities. These technological convergences enable more sophisticated data analysis, improved diagnostic accuracy, and enhanced connectivity that supports integrated healthcare delivery systems.

The healthcare sector's emphasis on portable, cost-effective diagnostic solutions with rapid response capabilities aligns perfectly with biosensor technology characteristics. Early and accurate disease identification represents a critical factor in positive patient outcomes and survival rates, creating sustained demand for advanced diagnostic technologies that can deliver reliable results in diverse healthcare settings.

Consumer healthcare trends toward regular pathogenic activity monitoring, driven by increasing prevalence of chronic and lifestyle-related conditions, support sustained market growth. The combination of aging global demographics and nanotechnology advancement improves biosensor accessibility and cost-effectiveness, expanding market reach across diverse patient populations.

Innovation and Product Development

The biosensors market benefits from continuous innovation in detection methodologies and device design, with companies developing increasingly sophisticated solutions that address specific healthcare challenges. Non-invasive testing technologies represent a significant advancement area, with saliva-based glucose monitoring systems offering alternatives to traditional blood-based testing methods.

Advanced biosensor designs incorporate rapid testing capabilities for bacterial and viral detection, enabling immediate assessment of whether additional medical consultation and testing are necessary. These developments support healthcare efficiency by providing initial screening capabilities that can guide subsequent care decisions.

Wearable biosensor technology demonstrates significant innovation momentum, with devices capable of real-time physiological monitoring including hydration status and electrolyte composition analysis. These systems integrate Bluetooth connectivity and mobile applications to provide continuous health monitoring with automated recommendations and alerts, creating comprehensive health management solutions.

Geographic Market Leadership and Strategic Developments

North America maintains a dominant market position driven by concentrated corporate innovation activity and advanced technology integration including artificial intelligence implementation. Regional market leadership reflects the concentration of research and development capabilities, regulatory infrastructure supporting innovation, and established healthcare technology adoption patterns.

Strategic partnerships between pharmaceutical companies and leading research institutions demonstrate industry commitment to advancing biosensor technology applications. These collaborations focus on developing integrated solutions combining biosensors, bioelectronics, and responsive delivery systems that create comprehensive healthcare management platforms.

The expansion of manufacturing capabilities for specialized biosensor applications, including interferometric-based systems for industrial and agricultural applications, indicates market diversification beyond traditional healthcare applications. These developments suggest growing recognition of biosensor technology's applicability across multiple industry sectors requiring precise biological or chemical detection capabilities.

Future Market Trajectory

Industry experts should anticipate continued biosensors market expansion driven by technological innovation, expanding healthcare applications, and increasing integration with digital health platforms that support comprehensive patient care management and monitoring solutions.

Key Benefits of this Report:

Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, and other sub-segments.
Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape future market developments.
Actionable Recommendations: Utilize the insights to exercise strategic decisions to uncover new business streams and revenues in a dynamic environment.
Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

Historical data from 2022 to 2024 & forecast data from 2025 to 2030
Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, and Trend Analysis
Competitive Positioning, Strategies, and Market Share Analysis
Revenue Growth and Forecast Assessment of segments and regions including countries
Company Profiling (Strategies, Products, Financial Information, and Key Developments among others.

The biosensors market has been analyzed through the following segments:

By Type

Electrochemical
Physical
Wearable
Thermal Detection
Others

By Application

Quality Control
Medical Diagnosis
Pesticide Control
Drug Development
Others

By End-User

Food & Beverage
Medical & Healthcare
Pharmaceutical
Agriculture
Others

By Geography

North America
USA
Canada
Mexico
South America
Brazil
Argentina
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Others
Middle East and Africa
Saudi Arabia
UAE
Israel
Others
Asia Pacific
China
India
Japan
South Korea
Indonesia
Thailand
Taiwan
Australia
Others

1. EXECUTIVE SUMMARY

2. MARKET SNAPSHOT

2.1. Market Overview
2.2. Market Definition
2.3. Scope of the Study
2.4. Market Segmentation

3. BUSINESS LANDSCAPE

3.1. Market Drivers
3.2. Market Restraints
3.3. Market Opportunities
3.4. Porter's Five Forces Analysis
3.5. Industry Value Chain Analysis
3.6. Policies and Regulations
3.7. Strategic Recommendations

4. TECHNOLOGICAL OUTLOOK

5. BIOSENSORS MARKET BY TYPE

5.1. Introduction
5.2. Electrochemical
5.3. Physical
5.4. Wearable
5.5. Thermal Detection
5.6. Others

6. BIOSENSORS MARKET BY APPLICATION

6.1. Introduction
6.2. Quality Control
6.3. Medical Diagnosis
6.4. Pesticide Control
6.5. Drug Development
6.6. Others

7. BIOSENSORS MARKET BY END-USER

7.1. Introduction
7.2. Food & Beverage
7.3. Medical & Healthcare
7.4. Pharmaceutical
7.5. Agriculture
7.6. Others

8. BIOSENSORS MARKET BY GEOGRAPHY

8.1. Introduction
8.2. North America
- 8.2.1. ByType
- 8.2.2. By Application
- 8.2.3. By End-User
- 8.2.4. By Country
  - 8.2.4.1. USA
  - 8.2.4.2. Canada
  - 8.2.4.3. Mexico
8.3. South America
- 8.3.1. By Type
- 8.3.2. By Application
- 8.3.3. By End-User
- 8.3.4. By Country
  - 8.3.4.1. Brazil
  - 8.3.4.2. Argentina
  - 8.3.4.3. Others
8.4. Europe
- 8.4.1. By Type
- 8.4.2. By Application
- 8.4.3. By End-User
- 8.4.4. By Country
  - 8.4.4.1. Germany
  - 8.4.4.2. France
  - 8.4.4.3. United Kingdom
  - 8.4.4.4. Italy
  - 8.4.4.5. Spain
  - 8.4.4.6. Others
8.5. Middle East and Africa
- 8.5.1. By Type
- 8.5.2. By Application
- 8.5.3. By End-User
- 8.5.4. By Country
  - 8.5.4.1. Saudi Arabia
  - 8.5.4.2. UAE
  - 8.5.4.3. Israel
  - 8.5.4.4. Others
8.6. Asia Pacific
- 8.6.1. By Type
- 8.6.2. By Application
- 8.6.3. By End-User
- 8.6.4. By Country
  - 8.6.4.1. China
  - 8.6.4.2. India
  - 8.6.4.3. Japan
  - 8.6.4.4. South Korea
  - 8.6.4.5. Indonesia
  - 8.6.4.6. Thailand
  - 8.6.4.7. Taiwan
  - 8.6.4.8. Australia
  - 8.6.4.9. Others